Compounds > chitosan
Page last updated: 2024-08-25

chitosan and Atherosclerotic Parkinsonism

chitosan has been researched along with Atherosclerotic Parkinsonism in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Alhakamy, NA; Anwer, MK; Bhattamisra, SK; Choudhury, H; Lim, WM; Md, S; Radhakrishnan, AK; Safian, NH; Shahzad, N; Shak, AT; Xi, LW1
Harish Prashanth, KV; Pramod Kumar, P1

Other Studies

2 other study(ies) available for chitosan and Atherosclerotic Parkinsonism

ArticleYear
Nose to brain delivery of rotigotine loaded chitosan nanoparticles in human SH-SY5Y neuroblastoma cells and animal model of Parkinson's disease.
    International journal of pharmaceutics, 2020, Apr-15, Volume: 579

    Topics: Administration, Intranasal; alpha-Synuclein; Animals; Blood-Brain Barrier; Cell Line, Tumor; Chitosan; Disease Models, Animal; Dopamine Agonists; Drug Carriers; Female; Haloperidol; Humans; Male; Nanoparticles; Neurons; Oxidopamine; Parkinson Disease, Secondary; Particle Size; Rats; Tetrahydronaphthalenes; Thiophenes; Toxicity Tests, Acute

2020
Diet with Low Molecular Weight Chitosan exerts neuromodulation in Rotenone induced Drosophila model of Parkinson's disease.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2020, Volume: 146

    Topics: Animals; Behavior, Animal; Chitosan; Drosophila melanogaster; Insecticides; Male; Motor Activity; Neurotransmitter Agents; Oxidative Stress; Parkinson Disease, Secondary; Reactive Oxygen Species; Rotenone

2020